1. Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030 2. Department of Cell and Developmental Biology, Weill Cornell Medical College of Cornell University, New York, New York 10021
This themed issue summarizes significant efforts aimed at using “biological language” to discern between “friends” and “foes” in the context of theranostics for true clinical application. It is expected that the success of theranostics depends on multidisciplinary efforts, combined to expedite our understanding of host responses to “customized” theranostic agents and formulating individualized therapies.